[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Pages 64675-64676]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-22521]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 26, 2007, and published in the Federal 
Register on July 5, 2007, (72 FR 36728), Boehringer Ingelheim 
Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of Lisdexamfetamine (1205), a 
basic class of controlled substance listed in schedule II.
    The company plans to qualify as a bulk manufacturer of the above 
listed controlled substance.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Boehringer Ingelheim Chemicals, Inc. to manufacture the listed basic 
class of controlled substance is consistent with the public interest at 
this time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. to 
ensure that the company's registration is consistent with the public 
interest. The

[[Page 64676]]

investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

    Dated: October 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-22521 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P